Strategic Growth Waters recently expanded through the Wyatt Technology acquisition in May 2023, and continues to grow its analytical instruments portfolio, presenting cross-sell opportunities for advanced light scattering, mass spectrometry, and separation technologies to existing life sciences and environmental science customers.

Clinical Diagnostics The launch of Xevo TQ Absolute XR IVD Mass Spectrometer and expansion of the MassTrak IVD System indicates a strong push into clinical diagnostics with high-sensitivity, robust LC-MS/MS solutions that can be paired with related assay kits and service offerings for hospitals, clinics, and reference labs.

Integrated Solutions Waters’ emphasis on combining analytical instruments with software and workflow solutions presents a sales angle for end-to-end lab modernization projects, including data management, instrument control, and analytics software deployment to improve lab efficiency and regulatory compliance.

At-Home Health Partnerships with at-home screening platforms like LetsGetChecked point to opportunities to co-develop or bundle portable or remote-testing workflows, enabling Waters to provide instrumentation, reagents, and software for decentralized diagnostics and population health programs.

Global Labs Footprint With a broad global reach in life, materials, food, and environmental sciences and a revenue mix reflecting steady growth, there are multi-region upsell possibilities across APAC, EMEA, and the Americas for new instrument generations, service contracts, and sustainability-focused analytical solutions.